Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-04

Clinical Trial Update: ADYNOVATE Drug Use-Results Survey

View source ↗

Summary

Takeda released results from a Hemophilia A drug-use survey of ADYNOVATE. The results were posted on February 4, 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADYNOVATE (efmoroctocog alfa)

Snippet

Sponsor: Takeda | Conditions: Hemophilia A | Status: COMPLETED | Results posted: 2025-02-04